Biomerica, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Biomerica, Inc. now
Current reporting with the operating signal separated from the noise.
Biomerica, Inc. Secures PLA Code for inFoods® IBS Test to Enhance Patient Access and Insurance Reimbursement
The story matters when it changes Biomerica, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025
Investors are testing whether Biomerica, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biomerica, Inc. (BMRA)
The story matters when it changes Biomerica, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest BMRA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Biomerica, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →